Table 3:

Periprocedural complications within 30 days after CAS according to age or presenting event and treatment

VariableUnprotected CASProtected CASP*
Age ≤75 y
    No.52138
    Minor stroke, n/N (%)4/52 (7.7)5/138 (3.6).3
    Major stroke, n/N (%)0/52 (0)0/138 (0)NA
    Death, n/N (%)0/52 (0)0/138 (0)NA
    Any stroke or death, n/N (%)4/52 (7.7)5/138 (3.6).3
Age >75 y
    No.1637
    Minor stroke, n/N (%)2/16 (12.5)2/37 (5.4).6
    Major stroke, n/N (%)0/16 (0)1/37 (2.7)1.0
    Death, n/N (%)0/16 (0)1/37 (2.7)1.0
    Any stroke or death, n/N (%)2/16 (12.5)4/37 (10.8)1.0
Symptomatic patients
    No.4787
    Minor stroke, n/N (%)5/47 (10.6)5/87 (5.7).3
    Major stroke, n/N (%)0/47 (0)0/87 (0)NA
    Death, n/N (%)0/47 (0)1/87 (1.1)1.0
    Any stroke or death, n/N (%)5/47 (10.6)6/87 (6.9)0.5
Asymptomatic patients
    No.2188
    Minor stroke, n/N (%)1/21 (4.8)2/88 (2.2).5
    Major stroke, n/N (%)0/21 (0)1/88 (1.1)1.0
    Death, n/N (%)0/21 (0)0/88 (0)NA
    Any stroke or death, n/N (%)1/21 (4.8)3/88 (3.4).6
  • Note:—CAS indicates carotid angioplasty and stent placement; NA, not applicable.

  • * P values are from χ2 analysis.

  • In the group of patients treated with cerebral protection devices, there was 1 nonstroke-related death secondary to pneumonia 3 weeks after the procedure.